Maintenance therapy with opium tincture for injecting drug users; implications for prevention from viral infections

Hepatitis Monthly

Volumn 13, Issue 4, 2013, Pages

  Alam Mehrjerdi, Zahra ^a   Zarghami, Mehran ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood Borne Pathogens; Health; Opium Tincture; Treatment

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; METHADONE; OPIATE;

CLINICAL EFFECTIVENESS; DRUG USE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MAINTENANCE THERAPY; PREVALENCE; SEIZURE; VIRUS INFECTION; WITHDRAWAL SYNDROME;

EID: 84878376768     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.8334     Document Type: Letter

References (20)

1. Alavi SM, Behdad F. Seroprevalence study of hepatitis C and Hepatitis B virus among hospitalized intravenous drug users in Ahvaz, Iran (2002-2006). Hepat Mon. 2010;10(2):101-4. [PubMed]
2. Amin-Esmaeili M, Rahimi-Movaghar A, Razaghi EM, Baghestani AR, Jafari S. Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran. Hepat Mon. 2012;12(1):23-31. [DOI] [PubMed]
3. Kassaian N, Adibi P, Kafashaian A, Yaran M, Nokhodian Z, Shoaei P, et al. Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran. Int J Prev Med. 2012;3(Suppl 1):S156-61. [PubMed]
4. Kheirandish P, Seyedalinaghi SA, Hosseini M, Jahani MR, Shirzad H, Foroughi M, et al. Prevalence and correlates of HIV infection among male injection drug users in detention in Tehran, Iran. J Acquir Immune Defic Syndr.2010;53(2):273-5. [DOI] [PubMed]
5. Hosseini M, SeyedAlinaghi S, Kheirandish P, Esmaeli Javid G, Shirzad H, Karami N, et al. Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran. Arch Iran Med. 2010;13(4):318-23. [PubMed]
6. Zamani S, Ichikawa S, Nassirimanesh B, Vazirian M, Ichikawa K, Gouya MM, et al. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. Int J Drug Policy. 2007;18(5):359-63. [DOI] [PubMed]
7. Fuller CM, Ompad DC, Galea S, Wu Y, Koblin B, Vlahov D. Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City. J Urban Health. 2004;81(1):20-4. [DOI] [PubMed]
8. Nataparan C. Methadone maintenance and harm reduction in northern Thailand. 2000; Available from:http://www.drugtext.org/Opiate.
9. Chandrasena R. Management of opium dependence in a general hospital psychiatry unit. Br J Addict.1980;75(2):163-7. [PubMed]
10. Somogyi AA, Larsen M, Abadi RM, Jittiwutikarn J, Ali R, White JM. Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. Br J Clin Pharmacol. 2008;66(5):640-7. [DOI] [PubMed]
11. Auriacombe M, Grabot D, Daulouede JP, Vergnolle JP, O'Brien C, Tignol J. A naturalistic follow-up study of French-speaking opiate-maintained heroin-addicted patients: effect on biopsychosocial status. J Subst Abuse Treat.1994;11(6):565-8. [PubMed]
12. Mokri A. Brief overview of the status of drug abuse in Iran. Arch Iranian Med. 2002;5(3):184-90.
13. United nations office on drug and crime. World drug report. 2011. Available from:http://www.unodc.org/unodc/en/.
14. Nissaramanesh B, Trace M, Roberts M. The rise of harm reduction in the Islamic Republic of Iran. Beckley Found Drug Policy Programme, Briefing Paper. 2005;8
15. Razzaghi E, Nassirimanesh B, Afshar P, Ohiri K, Claeson M, Power R. HIV/AIDS harm reduction in Iran. Lancet.2006;368(9534):434-5. [DOI] [PubMed]
16. Zamani S, Vazirian M, Nassirimanesh B, Razzaghi EM, Ono-Kihara M, Mortazavi Ravari S, et al. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program. AIDS Behav. 2010;14(4):885-90. [DOI] [PubMed]
17. Report of the International Narcotics Control Board. Analysis of the world situation. 2011; Available from:http://www.incb.org/documents/.
18. Lawrinson P, Ali R, Buavirat A, Chiamwongpaet S, Dvoryak S, Habrat B, et al. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction. 2008;103(9):1484-92. [DOI] [PubMed]
19. Razani N, Mohraz M, Kheirandish P, Malekinejad M, Malekafzali H, Mokri A, et al. HIV risk behavior among injection drug users in Tehran, Iran. Addiction. 2007;102(9):1472-82. [DOI] [PubMed]
20. Zarghami M. Is methadone substitution the best treatment of choice for opioid dependence? Iran J Psychiatry Behav Sci. 2008;2(2):1-4.